Pathology Industry in Australia Market Research & Statistics

24/7 Customer Support

Talk to Sam

+1 718 473 0872

All regions

About 1 600 reports

Download Unlimited Documents from Trusted Public Sources

Pathology Description in Australia

  • February 2015
    240 pages
  • Australia  

View report >

Pathology Description in Australia

  • January 2015
    5 pages
  • Hepatitis C  

  • Australia  

    Oceania  

View report >

Pathology Description in Australia

  • January 2015
    5 pages
  • Stroke  

  • Australia  

View report >

Pathology Description in Australia Forecast

  • January 2015
    14 pages
  • Hiv  

  • Australia  

    Oceania  

View report >

Pathology Description in Australia

  • January 2015
    8 pages
  • Cancer  

  • Australia  

    Oceania  

View report >

Pathology Description in Australia

  • December 2014
    44 pages
  • Asthma  

  • Australia  

View report >

Pathology Description in Australia

  • December 2014
    175 pages
  • Cancer  

  • Australia  

    Oceania  

View report >

Pathology Description in Australia

  • December 2014
    27 pages
  • Mental Health  

    Mental Illness  

  • Australia  

View report >

Pathology Description in Australia

  • November 2014
    16 pages
  • Pathology  

    General Medicin  

  • Australia  

    Oceania  

View report >

Pathology Description in Australia

  • November 2014
    6 pages
  • Mental Health  

  • Australia  

View report >


About 200 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 300 - $ 1 310)

Key Pharma News 02 FEBRUARY 2015

Key Pharma News 02 FEBRUARY 2015

  • $ 1 415
  • Industry report
  • February 2015
  • by Espicom Business Intelligence

Industry Trend Analysis - Approval Of Evotaz Will Keep BMS In HIV Market But Gilead Will Prevail Once Again Industry Trend Analysis - Several Stakeholders To Benefit From Gilead's Expanded Deals With Indian ...

Brinzolamide - Patent, Extension And Data Exclusivity ...

January 2015 $ 653

Duloxetine - Patent, Extension And Data Exclusivity Ex ...

January 2015 $ 653

Sildenafil - Patent, Extension And Data Exclusivity Ex ...

January 2015 $ 653

Sitagliptin - Patent, Extension And Data Exclusivity E ...

January 2015 $ 653

Temsirolimus - Patent, Extension And Data Exclusivity ...

January 2015 $ 653

Donepezil - Patent, Extension And Data Exclusivity Exp ...

January 2015 $ 653

Irbesartan - Patent, Extension And Data Exclusivity Ex ...

January 2015 $ 653

Rivastigmine - Patent, Extension And Data Exclusivity ...

January 2015 $ 653

Ropinirole - Patent, Extension And Data Exclusivity Ex ...

January 2015 $ 653


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.